Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Remifentanil (group R): Remifentanil administered as:
IV bolus: 1 µg/kg
Continuous infusion: 0.1 µg /kg/min,
May be combined with low-dose midazolam or propofol as needed
Control Int
Sponsors
GCS MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE
Eligibility
Inclusion criteria
Inclusion criteria: Willing to give consent ASA Physical Status I or II Undergoing elective ambulatory surgery
Exclusion criteria
Exclusion criteria: Known opioid allergy ASA 3,4 Severe cardiopulmonary disease Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate hemodynamic stability of remifentanil To evaluate analgesia and sedation of remifentanil patients undergoing ambulatory surgeries To assess the time to recovery and discharge readiness following remifentanil-Timepoint: at start of procedure, every 5,10,15 mins and then every 30 mins until end of procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare patient and surgeon satisfaction scores with remifentanil versus fentanyl To compare surgeon satisfaction scores with remifentanil versus fentanylTimepoint: at start of procedure, every 5,10,15 mins and then every 30 mins until end of procedure | — |
Countries
India
Contacts
Public ContactDr Divya Kheskani
GCS Medical college Hospital and Research Centre Ahmedabad
Outcome results
None listed